[SYRS] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
01-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -18.19%
YoY- -38.50%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 2,379 508 558 462 454 893 412 221.51%
PBT -17,226 -19,729 -19,793 -19,455 -16,461 -18,032 -15,737 6.20%
Tax 0 0 0 0 0 0 0 -
NP -17,226 -19,729 -19,793 -19,455 -16,461 -18,032 -15,737 6.20%
Tax Rate - - - - - - - -
Total Cost 19,605 20,237 20,351 19,917 16,915 18,925 16,149 13.78%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -724.09 -3,883.66 -3,547.13 -4,211.04 -3,625.77 -2,019.26 -3,819.66 -66.96%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -3.92 -4.60 -4.66 -4.67 -4.87 -5.35 -4.68 -11.13%
EPS Diluted -3.92 -4.49 -4.66 -4.67 -4.87 -5.34 -4.68 -11.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.